Share to Facebook Share to Twitter Bookmark and Share
File #: 22-733   
Status: Agenda Ready
In control: County Attorney
On agenda: 5/10/2022 Final action:
Title: MOTION TO APPROVE Participation Agreements regarding opioids litigation in substantially the form of Exhibits 1, 2, and 3; and to authorize the County Administrator to execute the Participation Agreements with any required modifications, provided such modifications do not impose any additional, material financial risk on the County, and subject to review and approval as to legal sufficiency by the Office of the County Attorney.
Attachments: 1. Exhibit 1 - Copy of Participation Agreement with CVS Pharmacy, 2. Exhibit 2 - Copy of Participation Agreement with Teva Pharmaceuticals, 3. Exhibit 3 - Copy of Participation Agreement with Allergan Pharmaceuticals, Inc.
Date Action ByActionResultAction DetailsMeeting DetailsVideo
No records to display.
Broward County Commission Regular Meeting
Director's Name: Andrew J. Meyers
Department: County Attorney

Information
Requested Action
title
MOTION TO APPROVE Participation Agreements regarding opioids litigation in substantially the form of Exhibits 1, 2, and 3; and to authorize the County Administrator to execute the Participation Agreements with any required modifications, provided such modifications do not impose any additional, material financial risk on the County, and subject to review and approval as to legal sufficiency by the Office of the County Attorney.

body
Why Action is Necessary
The Board's approval is required to resolve the County's pending claims against CVS Pharmacy ("CVS"), Teva Pharmaceuticals ("Teva"), and Allergan Pharmaceuticals, Inc. ("Allergan") (collectively, "Defendants").

What Action Accomplishes
Allows the Board to approve the Participation Agreements which, as part of a global settlement involving these Defendants, would settle and release the County's opioid claims against the Defendants.

Is this Action Goal Related
No

Previous Action Taken


Summary Explanation/Background
On September 21, 2021, the Board adopted Resolution No. 2021-464 (Item No. 51), which approved the Florida Opioid Allocation and Statewide Response Agreement (the "Florida Plan"). The Florida Plan provided the framework to resolve the pending claims against opioid drug distributors, manufacturers, marketers, and other potential parties in connection with the opioid epidemic. The material provisions of the Florida Plan provide that: (1) the Florida Attorney General is authorized to negotiate and enter into settlements with the defendants in the multidistrict opioid litigation on behalf of Florida's subdivisions and cities; (2) the settlement proceeds will be allocated into three funds (state, city/county, and regional); (3) certain large counties (including Broward County) can obtain the full regional fund if they become "Qualified Counti...

Click here for full text